Detalles de la búsqueda
1.
Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer.
Br J Cancer
; 121(9): 744-750, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31537908
2.
Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial.
Int J Radiat Oncol Biol Phys
; 109(4): 975-986, 2021 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33129910
3.
Clindamycin-paclitaxel pharmacokinetic interaction in ovarian cancer patients.
Cancer Chemother Pharmacol
; 58(3): 319-25, 2006 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16362296
4.
Changes in the management and outcome of central nervous system involvement from ovarian cancer since 1994.
Int J Gynaecol Obstet
; 114(2): 133-6, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21669416
5.
Phase III study of valspodar (PSC 833) combined with paclitaxel and carboplatin compared with paclitaxel and carboplatin alone in patients with stage IV or suboptimally debulked stage III epithelial ovarian cancer or primary peritoneal cancer.
J Clin Oncol
; 26(16): 2674-82, 2008 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18509179
6.
Differentiation of small adnexal masses based on morphologic characteristics of transvaginal sonographic imaging: a multicenter study.
J Ultrasound Med
; 24(11): 1467-73; quiz 1475-6, 2005 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16239647
Resultados
1 -
6
de 6
1
Próxima >
>>